U.S. Markets closed

Post-GSK purchase, Tesaro readies for cancer clash with Merck

Allison DeAngelis
Post-GSK purchase, Tesaro readies for cancer clash with Merck

A new GlaxoSmithKline subsidiary is developing another cancer-fighting drug that it believes could go toe-to-toe with the current market leader, Merck’s blockbuster drug Keytruda.